In animal health, the products will be mainly targeting mastitis and production disorders, gastrointestinal tract diseases, reproductive disorders, ectoparasites, and skin injuries
Sapropterin dihydrochloride powder for oral solution is available in 100 mg unit dose
Bharat Biotech expects to share further details of the trial results as additional data become available.
With this commissioning, Shilpa Medicare joins a very small group of Indian companies capable of offering end-to-end ADC Drug Substance development and manufacturing
Pharma powerhouse names Cecile Guegan interim finance chief
Bolstering neuroscience push with late-stage Tourette therapy
The FDA has granted Priority Review, setting a target decision date of 9 October 2026, potentially accelerating access to a new treatment option for a subset of patients with high-risk colon cancer characterized
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
Clearing 19 biologics for Europe market
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
